Literature DB >> 20489058

Cystatin C increases in cardiac injury: a role in extracellular matrix protein modulation.

Lifang Xie1, Jerome Terrand, Beibei Xu, George Tsaprailis, Jean Boyer, Qin M Chen.   

Abstract

AIMS: Numerous lines of evidence suggest a role of oxidative stress in initiation and progression of heart failure. We identify novel pathways of oxidative stress in cardiomyocytes using proteomic technology. METHODS AND
RESULTS: Cardiomyocytes and cardiac fibroblasts isolated from rat hearts were treated with sublethal doses of H(2)O(2) for detection of secreted protein factors in the conditioned media by mass spectrometry-based proteomics. Comparison between the two cell types leads to the finding that H(2)O(2) caused an elevated cystatin C protein in the conditioned medium from cardiomyocytes. When cardiomyopathy was induced in mice by chronic administration of doxorubicin, elevated cystatin C protein was detected in the plasma. Myocardial ischaemia by left anterior descending coronary artery occlusion causes an increase in the level of cystatin C protein in the plasma. In myocardial tissue from the ischaemic area, an increase in cystatin C correlates with the inhibition of cathepsin B activity and accumulation of fibronectin and collagen I/III. Overexpressing cystatin C gene or exposing fibroblasts to cystatin C protein results in an inhibition of cathepsin B and accumulation of fibronectin and collagen I/III.
CONCLUSION: Oxidants induce elevated cystatin C production from CMCs. Cystatin C plays a role in cardiac extracellular matrix remodelling.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20489058      PMCID: PMC2920813          DOI: 10.1093/cvr/cvq138

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  34 in total

Review 1.  Mitochondrial oxidative stress in heart failure: "oxygen wastage" revisited.

Authors:  D B Sawyer; W S Colucci
Journal:  Circ Res       Date:  2000-02-04       Impact factor: 17.367

2.  Tissue and biological fluid distribution of cysteine proteinases inhibitor: rat cystatin C.

Authors:  C Tavéra; D Prévot; J P Girolami; J Leung-Tack; A Collé
Journal:  Biol Chem Hoppe Seyler       Date:  1990-05

3.  Structure and expression of the human cystatin C gene.

Authors:  M Abrahamson; I Olafsson; A Palsdottir; M Ulvsbäck; A Lundwall; O Jensson; A Grubb
Journal:  Biochem J       Date:  1990-06-01       Impact factor: 3.857

4.  Attenuation of doxorubicin chronic toxicity in metallothionein-overexpressing transgenic mouse heart.

Authors:  X Sun; Z Zhou; Y J Kang
Journal:  Cancer Res       Date:  2001-04-15       Impact factor: 12.701

5.  Hydrogen peroxide dose dependent induction of cell death or hypertrophy in cardiomyocytes.

Authors:  Q M Chen; V C Tu; Y Wu; J J Bahl
Journal:  Arch Biochem Biophys       Date:  2000-01-01       Impact factor: 4.013

6.  Cystatin C deficiency in human atherosclerosis and aortic aneurysms.

Authors:  G P Shi; G K Sukhova; A Grubb; A Ducharme; L H Rhode; R T Lee; P M Ridker; P Libby; H A Chapman
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

7.  Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis.

Authors:  Vikas R Dharnidharka; Charles Kwon; Gary Stevens
Journal:  Am J Kidney Dis       Date:  2002-08       Impact factor: 8.860

8.  Human evidence that the cystatin C gene is implicated in focal progression of coronary artery disease.

Authors:  Per Eriksson; Hiroyuki Deguchi; Ann Samnegård; Pia Lundman; Susanna Boquist; Per Tornvall; Carl-Göran Ericsson; Lott Bergstrand; Lars-Olof Hansson; Shu Ye; Anders Hamsten
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-01-15       Impact factor: 8.311

9.  Mouse cardiac surgery: comprehensive techniques for the generation of mouse models of human diseases and their application for genomic studies.

Authors:  Oleg Tarnavski; Julie R McMullen; Martina Schinke; Qing Nie; Sekwon Kong; Seigo Izumo
Journal:  Physiol Genomics       Date:  2004-02-13       Impact factor: 3.107

Review 10.  Molecular regulation of human cathepsin B: implication in pathologies.

Authors:  Shiqing Yan; Bonnie F Sloane
Journal:  Biol Chem       Date:  2003-06       Impact factor: 3.915

View more
  26 in total

1.  Cystatin C and galectin-3 as therapeutic targets in heart failure.

Authors:  Christos Zivlas; Filippos Triposkiadis; Stelios Psarras; Gregory Giamouzis; Ioannis Skoularigis; Stavros Chryssanthopoulos; Alkistis Kapelouzou; Steve Ramcharitar; Edward Barnes; Evangelos Papasteriadis; Dennis Cokkinos
Journal:  Ther Adv Cardiovasc Dis       Date:  2018-05-31

2.  Left atrial volume index in patients with heart failure and severely impaired left ventricular systolic function: the role of established echocardiographic parameters, circulating cystatin C and galectin-3.

Authors:  Christos Zivlas; Filippos Triposkiadis; Stelios Psarras; Gregory Giamouzis; Ioannis Skoularigis; Stavros Chryssanthopoulos; Alkistis Kapelouzou; Steve Ramcharitar; Edward Barnes; Evangelos Papasteriadis; Dennis Cokkinos
Journal:  Ther Adv Cardiovasc Dis       Date:  2017-08-22

3.  Regulation of TGF-β1-driven differentiation of human lung fibroblasts: emerging roles of cathepsin B and cystatin C.

Authors:  Mariana Kasabova; Alix Joulin-Giet; Fabien Lecaille; Brendan F Gilmore; Sylvain Marchand-Adam; Ahlame Saidi; Gilles Lalmanach
Journal:  J Biol Chem       Date:  2014-04-30       Impact factor: 5.157

Review 4.  Managing chemotherapy-related cardiotoxicity in survivors of childhood cancers.

Authors:  Steven E Lipshultz; Melissa B Diamond; Vivian I Franco; Sanjeev Aggarwal; Kasey Leger; Maria Verônica Santos; Stephen E Sallan; Eric J Chow
Journal:  Paediatr Drugs       Date:  2014-10       Impact factor: 3.022

5.  Higher cystatin C level predicts long-term mortality in patients with peripheral arterial disease.

Authors:  Grazina Urbonaviciene; Guo Ping Shi; Sigitas Urbonavicius; Eskild W Henneberg; Jes S Lindholt
Journal:  Atherosclerosis       Date:  2011-02-18       Impact factor: 5.162

Review 6.  Association Between Cystatin C and the Risk of Ischemic Stroke: a Systematic Review and Meta-analysis.

Authors:  Yan Wang; Wei Li; Jun Yang; Mijuan Zhang; Chun'e Tian; Minjiang Ma; Qian Zhang
Journal:  J Mol Neurosci       Date:  2019-07-17       Impact factor: 3.444

7.  Developmental regulation of synthesis and dimerization of the amyloidogenic protease inhibitor cystatin C in the hematopoietic system.

Authors:  Yuekang Xu; Petra Lindemann; Javier Vega-Ramos; Jian-Guo Zhang; Jose A Villadangos
Journal:  J Biol Chem       Date:  2014-02-25       Impact factor: 5.157

Review 8.  The tell-tale heart: molecular and cellular responses to childhood anthracycline exposure.

Authors:  Merry L Lindsey; Richard A Lange; Helen Parsons; Thomas Andrews; Gregory J Aune
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-09-12       Impact factor: 4.733

9.  Redox proteins are constitutively secreted by skeletal muscle.

Authors:  Yasuko Manabe; Mayumi Takagi; Mio Nakamura-Yamada; Naoko Goto-Inoue; Masato Taoka; Toshiaki Isobe; Nobuharu L Fujii
Journal:  J Physiol Sci       Date:  2014-09-10       Impact factor: 2.781

10.  Nrf2 protects mitochondrial decay by oxidative stress.

Authors:  Joshua Strom; Beibei Xu; Xiuqing Tian; Qin M Chen
Journal:  FASEB J       Date:  2015-09-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.